BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29507462)

  • 1. The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies.
    Ridola L; Cardinale V; Riggio O
    Ann Gastroenterol; 2018; 31(2):151-164. PubMed ID: 29507462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in patients with minimal hepatic encephalopathy.
    Ridola L; Nardelli S; Gioia S; Riggio O
    World J Gastroenterol; 2018 Dec; 24(48):5446-5453. PubMed ID: 30622374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal Hepatic Encephalopathy Affects Daily Life of Cirrhotic Patients: A Viewpoint on Clinical Consequences and Therapeutic Opportunities.
    Faccioli J; Nardelli S; Gioia S; Riggio O; Ridola L
    J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy.
    Nardelli S; Gioia S; Faccioli J; Riggio O; Ridola L
    World J Gastroenterol; 2019 Sep; 25(35):5257-5265. PubMed ID: 31558871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal hepatic encephalopathy: A review.
    Nardone R; Taylor AC; Höller Y; Brigo F; Lochner P; Trinka E
    Neurosci Res; 2016 Oct; 111():1-12. PubMed ID: 27153746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Moran S; López-Sánchez M; Milke-García MDP; Rodríguez-Leal G
    World J Gastroenterol; 2021 Jun; 27(22):3050-3063. PubMed ID: 34168407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic Encephalopathy: Diagnosis and Management.
    Ridola L; Faccioli J; Nardelli S; Gioia S; Riggio O
    J Transl Int Med; 2020 Dec; 8(4):210-219. PubMed ID: 33511048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal hepatic encephalopathy.
    Dhiman RK; Chawla YK
    Indian J Gastroenterol; 2009; 28(1):5-16. PubMed ID: 19529896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy.
    Felipo V; Urios A; Valero P; Sánchez M; Serra MA; Pareja I; Rodríguez F; Gimenez-Garzó C; Sanmartín J; Montoliu C
    Liver Int; 2013 Nov; 33(10):1478-89. PubMed ID: 23714168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal hepatic encephalopathy.
    Stinton LM; Jayakumar S
    Can J Gastroenterol; 2013 Oct; 27(10):572-4. PubMed ID: 24106728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal hepatic encephalopathy: diagnosis by neuropsychological and neurophysiologic methods.
    Kharbanda PS; Saraswat VA; Dhiman RK
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S37-41. PubMed ID: 15025253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study.
    Rathi S; Chopra M; Chouduri G; Sharma P; Madan K; Chhabra M; Rai RR; Govil A; Konar A; Goenka M; Agarwal M; Mukherjee J; Thorat V; Salunkhe S; Abraham P; Nagral A; Jhaveri A; Bhat N; Varghese J; R S A; Ravishankar ; Reddy DC; Dhiman RK
    J Clin Exp Hepatol; 2019; 9(4):476-483. PubMed ID: 31516264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial.
    Sharma K; Pant S; Misra S; Dwivedi M; Misra A; Narang S; Tewari R; Bhadoria AS
    Saudi J Gastroenterol; 2014; 20(4):225-32. PubMed ID: 25038208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic encephalopathy - recent advances in treatment and diagnosis.
    Nardelli S; Gioia S; Faccioli J; Riggio O; Ridola L
    Expert Rev Gastroenterol Hepatol; 2023 Mar; 17(3):225-235. PubMed ID: 36843291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Minimal hepatic encephalopathy].
    Jover M; Hoyas E; Grande L; Romero-Gómez M
    Rev Gastroenterol Mex; 2009; 74(1):26-34. PubMed ID: 19666316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota.
    Wang MW; Ma WJ; Wang Y; Ma XH; Xue YF; Guan J; Chen X
    Front Microbiol; 2023; 14():1091167. PubMed ID: 37032856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covert hepatic encephalopathy: not as minimal as you might think.
    Kappus MR; Bajaj JS
    Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1208-19. PubMed ID: 22728384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.